Biomarkers for preclinical Alzheimer's disease
Author(s)
Bibliographic Information
Biomarkers for preclinical Alzheimer's disease
（Neuromethods, 137）（Springer protocols）
Humana Press, c2018
- : pbk
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This volume discusses the importance of imaging, fluid, and genetic biomarkers in detecting the earliest pre-symptomatic stages of Alzheimer's disease (AD). The chapters in this book are separated into five parts. Part one explores the reasons why we need improved approaches for early detection and diagnosis of AD. Part two describes clinical and research techniques for preclinical AD diagnosis. Part three looks at the current methods in use to diagnose AD and how they can also be used for early detection in healthy older individuals. Parts four and five talk about technological advancements in AD diagnosis and ethical considerations in AD research. In Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Comprehensive and cutting-edge, Biomarkers for Preclinical Alzheimer's Disease is a valuable resource for individuals interested in the use of biomarker strategies to improve early AD detection. This book will be of great interest to researchers and clinicians from both academia and industry."
Table of Contents
Series Preface...
Preface...
Table of Contents...
Contributing Authors...
Part I Alzheimer's Disease as a Societal Challenge
1. Worldwide Economic Costs and Societal Burden of Dementia
Junfang Xu and Chengxuan Qiu
2. Epidemiology and Risk Factors of Alzheimer's Disease: A Focus on Diet
Cecilia Samieri
Part II Diagnostic Concepts
3. The Dimensional Structure of Subjective Cognitive Decline
Miguel A. Fernandez-Blazquez, Marina Avila-Villanueva, and Miguel Medina
4. Deriving and Testing the Validity of Cognitive-Reserve Candidates
Yaakov Stern and Christian Habeck
5. Methods for Pathological Classification of Alzheimer's Disease
Johannes Attems, Kirsty E. McAleese, and Lauren Walker
Part III Established Markers of Pathophysiology and Risk
6. Cerebrospinal Fluid Biomarkers of Preclinical Alzheimer's Disease
Panagiotis Alexopoulos and Chaido Sirinian
7. Brain Structural Imaging in Alzheimer's Disease
Sven Haller, Davide Zanchi, Cristelle Rodriguez, and Panteleimon Giannakopoulos
8. Brain Functional Imaging in Preclinical Alzheimer's Disease
Peter Haussermann, Thorsten Bartsch, and Oliver Granert
9. Imaging of Brain Amyloid Load in Early Alzheimer's Disease
Timo Grimmer and Jennifer Grace Perryman
10. Functional EEG Connectivity Alterations in Alzheimer's Disease
Florian Hatz and Peter Fuhr
Part IV Biomarker Discovery
11. A Selected Reaction Monitoring Protocol for the Measurement of sTREM2 in Cerebrospinal Fluid
Amanda J. Heslegrave, Wendy E. Heywood, Kevin M. Mills, Henrik Zetterberg
12. Soluble Amyloid Precursor Proteins in Blood: Methods and Challenges
Robert Perneczky and Panagiotis Alexopoulos
13. Tau Imaging in Preclinical Alzheimer's Disease
Paul Edison
14. Retinal Imaging in Early Alzheimer's Disease
Tom MacGillivray, Sarah McGrory, Tom Pearson, and James Cameron
15. In Vivo Volumetry of the Cholinergic Basal Forebrain
Michel J. Grothe, Ingo Kilimann, Lea Grinberg, Helmut Heinsen, and Stefan Teipel
Part V Patient Benefit and Ethical Considerations
16. Clinical Meaningfulness of Biomarkers Endpoints in Alzheimer's Disease Research
Kok Pin Ng, Tharick A. Pascoal, Xiaofeng Li, Pedro Rosa-Neto, and Serge Gauthier
17. The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer's Disease
Alexander F. Kurz and Nicola T. Lautenschlager
18. Shared Decision-Making and Important Medical and Social Decisions in the Context of Early Diagnosis of Alzheimer's Disease
Katharina Bronner and Johannes Hamann
by "Nielsen BookData"
